Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by gojotv!on Apr 06, 2021 7:44pm
97 Views
Post# 32946601

RE:RE:A short math lesson...

RE:RE:A short math lesson...Hello? Before these patients came for care and cocktails, they came for tests, right?
And many, many people were released when their tests came out negative, right?
The 3000 are the people who tested positive and who are NOT our market.
Get that into your head.
Our market is the tens of thousands who want an easy, comprehensive, time-saving,
no flattenned, irradiated breast,
no snaking camera tube up the guts,
no painful tissue biopsy,
no barium X-ray
TEST.
Basically, our market is anyone who wants a panel of cancer tests! Think of the time and pain saved!
Do you guys not understand what we have here?
ANNND... Get this! It's recurring income!
Because these patients will want this test again in the future!
Now, add to that patients in remission. And add to that geographic scope...  Have a sit and think, and shame on those who are trying to minimize this.
I would love to see if their trading reflects their posts, but I suspect it doesn't.
Govern yourselves accordingly. There are sharks in the water.



Eagles1968 wrote: That's not it at all. They come to care oncology for treatment to take their cocktails of drugs to treat their cancer!


<< Previous
Bullboard Posts
Next >>